FundedIQ
Biotechnology

Sera Medicines: Funding, Investors & Team (Oct 2026)

Sera Medicines is an operator of biologics accelerator developing and launching next-generation protein therapeutics.

www.seramedicines.com LinkedIn Boston, United States 11-50 employees
Biotechnology Health Care Therapeutics Wellness
Total raised
$38.0M
Rounds
1
Latest
Undisclosed round
Jun 2026

Sera Medicines has raised $38.0M across 1 funding round on record, the most recent an undisclosed round of $38.0M announced in Jun 2026.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Sera Medicines Company Profile and Key Stats

Total funding raised
$38.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$38.0M in Jun 2026
Employees
11-50
reported band
Headquarters
Boston, United States

Latest funding round on record: Jun 2026.

Sera Medicines Funding Rounds

Date
Round
Amount
Undisclosed round
$38.0M

Sera Medicines Founders and Leadership Team

Name
Role
Contact
Stephen Thomas
Founder
—

No contact details are on record for this team yet.

Sera Medicines Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Sera Medicines' latest round of $38.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Sera Medicines in Biotechnology and Boston

Companies Similar to Sera Medicines

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Sera Medicines Funding FAQs

What does Sera Medicines do?

Sera Medicines is an operator of biologics accelerator developing and launching next-generation protein therapeutics.

How much funding has Sera Medicines raised?

Sera Medicines has raised $38.0M across 1 round on record. The most recent is an undisclosed round of $38.0M announced in Jun 2026.

When did Sera Medicines last raise funding?

Sera Medicines' most recent funding round on record is an undisclosed round of $38.0M, announced in Jun 2026.

Who founded Sera Medicines?

FundedIQ lists Stephen Thomas (Founder) at Sera Medicines.

Where is Sera Medicines headquartered?

Sera Medicines is based in Boston, Massachusetts, United States.

How many employees does Sera Medicines have?

Sera Medicines is in the 11-50 employee band.

How does Sera Medicines' funding compare to other Biotechnology startups?

Sera Medicines' latest round of $38.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Sera Medicines Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sera Medicines is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.